Shares of Genzyme (Nasdaq: GENZ) are now trading well into positive territory following reports from CNBC's David Faber ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE